Evaluation of stem cell administration in a model of kidney ischemia-reperfusion injury

International Immunopharmacology

Volumn 7, Issue 13, 2007, Pages 1609-1616

  da Silva, Léa Bueno Lucas ^a   Palma, Patrícia Viana Bonini ^b   Cury, Patrícia Maluf ^a   Bueno, Valquiria ^c  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone marrow stem cells; Immunosuppression; Ischemia reperfusion injury; Leukocytes; Renal function

Indexed keywords

FINGOLIMOD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CELL ACTIVATION; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SPLEEN CELL; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION;

ANIMALS; CREATININE; DISEASE MODELS, ANIMAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KIDNEY; MALE; MICE; MICE, INBRED C57BL; NECROSIS; PROPYLENE GLYCOLS; REPERFUSION INJURY; SPHINGOSINE;

EID: 35748950407     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.08.014     Document Type: Article

References (36)

1. Thadhani R., Pascual M., and Bonventre J.V. Acute renal failure. New Engl J Med 334 (1996) 1448-1460
2. ZuK A., Bonventre J.V., Brown D., and Matlin K.S. Polarity, integrin and extracellular matrix dynamics in the postischemic rat kidney. Am J Physiol 275 (1998) C711-C731
3. Witzgall R., Brown D., Schwarz C., and Bonventre J.V. Localization of proliferating cell nuclear antigen, vimentin, c-Fos and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93 (1994) 2175-2188
4. Al-Awqati Q., and Oliver J.A. Stem cells in the kidney. Kidney Int 61 (2002) 387-395
5. Kitamura S., Yamasaki Y., Kinomura M., Sugaya T., Sugiyama H., Maeshima Y., et al. Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J 19 (2005) 1789-1797
6. Duffield J.S., and Bonventre J.V. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 68 (2005) 1956-1961
7. Andrade C.F., Waddell T.K., Keshavjee S., and Liu M. Innate immunity and organ transplantation: the potential role of toll-like receptors. Am J Transplant 5 (2005) 969-975
8. Leemans J.C., Stokman G., Claessen N., Rouschop K.M., Teske G.J., Kirschning C.J., et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115 (2005) 2894-2903
9. Mizuno S., and Nakamura T. Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 166 (2005) 1895-1905
10. Ysebaert D.K., De Greef K.E., De Beuf A., Van Rompay A.R., Vercauteren S., Persy V.P., et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 66 (2004) 491-496
11. Ortiz A.M., Troncoso P., and Kahan B.D. Prevention of renal ischemic reperfusion injury using FTY720 and ICAM-1 antisense oligonucleotides. Transplant Proc 35 (2003) 1571-1574
12. Dragun D., Bohler T., Nieminen-Kelha M., Waiser J., Schneider W., Haller H., et al. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int 65 (2004) 1076-1083
13. Oliveira C.M., Borra R.C., Franco M., Schor N., Silva Jr. H.T., Pestana J.O., et al. FTY720 impairs necrosis development after ischemia-reperfusion injury. Transplant Proc 36 (2004) 854-856
14. Suleiman M., Cury P.M., Pestana J.O., Burdmann E.A., and Bueno V. FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury. Transplant Proc 37 (2005) 373-374
15. Galvão V.R., Ginoza M., Franco M., Burdmann E.A., and Bueno V. Prolonged administration of FTY720 does not cause renal toxicity in mice. Transplant Proc 37 (2005) 112-113
16. Silva F.R., Silva L.B., Cury P.M., Burdmann E.A., and Bueno V. FTY720 in combination with cyclosporine - an analysis of skin allograft survival. Int Immunopharmacol 6 (2006) 1911-1918
17. Chiba K. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol Ther 108 (2005) 308-319
18. Vaessem L.M.B., van Besouw N.M., Mol W.M., Ijzermans J.N.M., and Weimar W. FTY720 treatment of kidney transplant patients: a differential effect on B cells, naïve T cells, memory T cells and NK cells. Transpl Immunol 15 (2006) 281-288
19. Poulsom R., Alison M.R., Cook T., Jeffery R., Eoin R., Forbes S.J., et al. Bone marrow stem cells contribute to healing of the kidney. J Am Soc Nephrol 14 (2003) S48-S54
20. Rabb H., Daniels F., O'Donnell M., Haq M., Saba S.R., Keane W., et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 279 (2003) F525-F551
21. Kale S., Karihaloo A., Clark P.R., Kashgarian M., Krause D.S., and Cantley L.G. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 112 (2003) 42-49
22. Bonventre J.V. Mechanisms of ischemic acute renal failure. Kidney Int 43 (1993) 1160-1178
23. Sutton T.A., and Molitoris B.A. Mechanisms of cellular injury is ischemic acute renal failure. Sem Nephrol 18 (1998) 490-497
24. Venkatachalam M.A., Bernard D.B., Donohoe J.F., and Levinsky N.G. Ischemic change and repair in the rat proximal tubule: differences among the S1, S2 and S3 segments. Kidney Int 14 (1978) 31-49
25. Jennische E., and Andersson G. Selective damage to S3-segments in post-ischemic kidney as demonstrated by a single histochemical method. Acta Pathol Microbiol Immunol Scand 94 (1986) 167-168
26. Gobe G., Willgoss D., Hogg N., Schoch E., and Endre Z. Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int 56 (1999) 1299-1304
27. Ysebaert D.K., De Greef K.E., Vercauteren S.R., Verhulst A., Kockx M., Verpooten G.A., et al. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int 64 (2003) 864-873
28. Brinkman V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biochem Mol Biol 14 (2004) 21453-21457
29. Sanchez T., Estrada-Hernandez T., Paik J.H., Wu MT., Venkataraman K., Brinkmann V., et al. J Biol Chem 278 (2003) 47281-47290
30. Xin C., Ren S., Eberhardt W., Pfeilschifter J., and Huwiler A. The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells. Br J Pharmacol 147 (2006) 164-174
31. Genesca M., Sola A., and Hotter G. Actin cytoskeleton derangement induces apoptosis in renal ischemia/reperfusion. Apoptosis 11 (2006) 563-571
32. Bailly-Maitre B., Fondevila C., Kaldas F., Droin N., Luciano F., Ricci J.E., et al. Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury. PNAS 103 (2006) 2809-2814
33. Troncoso P., Ortiz M., Martinez L., and Kahan B.D. FTY720 presents ischemic reperfusion damage in rat kidneys. Transplant Proc 33 (2001) 857-859
34. Togel F., Isaac J., and Westenfelder C. Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure. J Am Soc Nephrol 15 (2004) 1261-1267
35. Duffield J.S., Park K.M., Hsiao L.L., Kelley V.R., Scadden D.T., Ichimura T., et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. JCI 115 (2005) 1743-1755
36. Lin F., Moran A., and Igarashi P. Intrarenal cells, not bone marrow-derived cells are the major source for regeneration in postischemic kidney. JCI 115 (2005) 1756-1764